Cardiol Therapeutics Inc. (CRDL)
USD 1.14
(1.79%)
USD 1.14
(1.79%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -248.35 Thousand CAD | -12.94% |
| 2022 | -219.9 Thousand CAD | -379.21% |
| 2021 | 78.76 Thousand CAD | 134.31% |
| 2020 | -229.53 Thousand CAD | -52.44% |
| 2019 | -150.57 Thousand CAD | -64.57% |
| 2018 | -91.49 Thousand CAD | -71.52% |
| 2017 | -53.34 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -61.62 Thousand CAD | 7.7% |
| 2024 Q2 | -61.9 Thousand CAD | -0.46% |
| 2023 Q3 | -64.89 Thousand CAD | -10.94% |
| 2023 FY | -248.35 Thousand CAD | -12.94% |
| 2023 Q1 | -58.2 Thousand CAD | -0.29% |
| 2023 Q2 | -58.49 Thousand CAD | -0.5% |
| 2023 Q4 | -66.76 Thousand CAD | -2.88% |
| 2022 FY | -219.9 Thousand CAD | -379.21% |
| 2022 Q1 | -53.62 Thousand CAD | 3.54% |
| 2022 Q4 | -58.03 Thousand CAD | -6.53% |
| 2022 Q3 | -54.47 Thousand CAD | -1.29% |
| 2022 Q2 | -53.77 Thousand CAD | -0.3% |
| 2021 Q3 | -55.58 Thousand CAD | -170.58% |
| 2021 Q4 | -55.59 Thousand CAD | -0.0% |
| 2021 Q2 | 78.76 Thousand CAD | 244.2% |
| 2021 FY | 78.76 Thousand CAD | 134.31% |
| 2021 Q1 | -54.62 Thousand CAD | 0.0% |
| 2020 FY | -229.53 Thousand CAD | -52.44% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 FY | -150.57 Thousand CAD | -64.57% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | -91.49 Thousand CAD | -71.52% |
| 2018 Q2 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 FY | -53.34 Thousand CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 73.06 Million USD | 100.34% |
| Theratechnologies Inc. | 62.12 Million USD | 100.4% |
| Safety Shot Inc | -74.45 Thousand USD | -233.555% |
| Cosmos Health Inc. | 4.34 Million USD | 105.71% |
| Cronos Group Inc. | 6.99 Million USD | 103.553% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 100.056% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 18.035% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 100.08% |
| Universe Pharmaceuticals INC | 10.07 Million USD | 102.464% |
| ProPhase Labs, Inc. | 16.23 Million USD | 101.529% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | 105.234% |
| Dynavax Technologies Corporation | 182.11 Million USD | 100.136% |
| Radius Health, Inc. | 307.71 Million USD | 100.081% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | 144.832% |
| Alvotech | -69.42 Million USD | 99.642% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 102.978% |
| Alpha Teknova, Inc. | 10.29 Million USD | 102.412% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 100.058% |
| SCYNEXIS, Inc. | 124.51 Million USD | 100.199% |
| Harrow Health, Inc. | 90.55 Million USD | 100.274% |
| Biofrontera Inc. | 16.62 Million USD | 101.494% |
| DURECT Corporation | 6.83 Million USD | 103.636% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 100.047% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 100.081% |
| OptiNose, Inc. | 62.35 Million USD | 100.398% |
| RedHill Biopharma Ltd. | 3.05 Million USD | 108.132% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 100.835% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 100.742% |
| SIGA Technologies, Inc. | 122.09 Million USD | 100.203% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 100.593% |
| Shineco, Inc. | 882.16 Thousand USD | 128.153% |
| Phibro Animal Health Corporation | 312.48 Million USD | 100.079% |
| Procaps Group S.A. | 239.56 Million USD | 100.104% |
| TherapeuticsMD, Inc. | 1.3 Million USD | 119.075% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 66.69% |
| Viatris Inc. | 6.43 Billion USD | 100.004% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 102.978% |
| Rockwell Medical, Inc. | 8.7 Million USD | 102.853% |
| Incannex Healthcare Limited | 12 Thousand USD | 2169.625% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 100.455% |
| Tilray Brands, Inc. | 223.35 Million USD | 100.111% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 100.076% |
| PetIQ, Inc. | 252.74 Million USD | 100.098% |
| Silver Spike Investment Corp. | 8.1 Million USD | 103.065% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 100.013% |
| Journey Medical Corporation | 52.52 Million USD | 100.473% |
| Alimera Sciences, Inc. | 61.17 Million USD | 100.406% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | 105.926% |
| Assertio Holdings, Inc. | 125.04 Million USD | 100.199% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | -3546.381% |
| Embecta Corp. | 749.9 Million USD | 100.033% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 89.696% |
| Procaps Group, S.A. | 239.56 Million USD | 100.104% |
| PainReform Ltd. | -15 Thousand USD | -1555.7% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 100.916% |
| Hempacco Co., Inc. | -1.21 Million USD | 79.573% |
| Talphera, Inc. | -4.89 Million USD | 94.926% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 100.051% |
| Alvotech | -69.42 Million USD | 99.642% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 100.035% |
| Kamada Ltd. | 52.59 Million USD | 100.472% |
| Indivior PLC | 907 Million USD | 100.027% |
| Currenc Group, Inc. | 17.35 Million USD | 101.431% |
| Evoke Pharma, Inc. | 4.97 Million USD | 104.988% |
| Flora Growth Corp. | 17.73 Million USD | 101.4% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 89.696% |
| Evolus, Inc. | 140.52 Million USD | 100.177% |
| HUTCHMED (China) Limited | 453.55 Million USD | 100.055% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 100.072% |
| Akanda Corp. | 111.44 Thousand USD | 322.842% |